Appropriate Use Criteria

Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.

Click here to get answers to your reimbursement questions regarding Appropriate Use Criteria.

Comments or Questions?

The SNMMI Guidance Oversight Committee is continually developing new Appropriate Use Criteria (AUC) and reviewing and updating existing AUC. If you have specific comments or questions on the content of any of the AUC, or if you have suggestions for new AUC that you feel should be written, please contact the SNMMI Guidance Oversight Committee at [email protected]. All comments will be considered in the AUC development process.

Articles
Data pager
Data pager
12
Page size:
PageSizeComboBox
select
 17 items in 2 pages
Show all 17
SNMMI and the Alzheimer’s Association and their designated experts, collaborated to update this Appropriate Use Criteria (AUC) document. The primary goal of this AUC is to assist clinicians in identifying clinical scenarios in which amyloid or tau P
Status: Approved
Jun 07, 2024
6/7/2024 12:00:00 AM
SNMMI assembled an autonomous Workgroup to represent a multidisciplinary panel of health care providers with substantive knowledge in the use of nuclear medicine in 177Lu-PSMA-617 Radionuclide Therapy to review the scientific literature and develop c
Status: Approved
Apr 26, 2023
4/26/2023 12:00:00 AM
SNMMI assembled an autonomous Workgroup to represent a multidisciplinary panel of health care providers with substantive knowledge in the use of nuclear medicine in fever of unknown origin to review the scientific literature and develop consensus rec
Status: Approved
Jan 08, 2023
1/8/2023 12:00:00 AM
To guide referring and imaging physicians to use Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17β-Fluoroestradiol, the Society of Nuclear Medicine and Molecular Imaging (SNMMI), American College of Nuclear Medicine (ACNM), and Lobular B
Status: Approved
Oct 08, 2022
10/8/2022 12:00:00 AM
To guide referring and imaging physicians to use PSMA PET imaging agents appropriately, The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American College of Nuclear Medicine (ACNM), American Urological Association (AUA), Australia and N
Status: Approved
Sep 15, 2021
9/15/2021 12:00:00 AM
To guide referring and imaging physicians to use Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema, the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Society for Vascular Medicine (SVM), Australia and New Zealand Societ
Status: Approved
May 16, 2021
5/16/2021 5:17:00 PM
To improve utilization and guide providers to use Musculoskeletal Infection Imaging in a more appropriate way, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American College of Nuclear Medicine (ACNM) will collaboratively deve
Status: Approved
Mar 15, 2021
3/15/2021 12:00:00 AM
The new AUC for PET Myocardial Perfusion Imaging addresses several clinical scenarios for nuclear medicine. To improve utilization and guide providers to use nuclear medicine for coronary artery disease and cardiovascular risk stratification in a mor
Status: Approved
Mar 29, 2020
3/29/2020 10:41:00 AM
The new AUC for Imaging Evaluation of Biochemical Recurrence (BCR) of Prostate Cancer After Definitive Primary Treatment addresses several clinical scenarios for nuclear medicine. To improve utilization and guide providers to use nuclear medicine for
Status: Approved
Sep 27, 2019
9/27/2019 10:48:00 AM
The new AUC for gastrointestinal (GI) transit scintigraphy addresses several clinical scenarios for GI motility. To improve utilization and guide providers to use GI transit scintigraphy for motility in a more appropriate way, the Society of Nuclear
Status: Approved
Sep 27, 2019
9/27/2019 12:00:00 AM